IMR Press / JIN / Special Issues / 1588734408215

Neurodegeneration and neuroinflammation

Submission deadline: 01 March 2021
Special Issue Editor
  • Jolanta Dorszewska
    Laboratory of Neurobiology, Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland
    Interests: Alzheimer’s disease; Parkinson’s disease; Epilepsy; Genetics; genomics; Molecular biology; Clinical trials; Genetic analysis; Neurodegeneration; Neurological diseases; Neurodegenerative diseases; Neurobiology
Special Issue Information

Dear Colleagues,


The causes of central neurodegenerative changes in the course of neurological diseases such as Alzheimer's disease and Parkinson's disease and many others are not fully explained. It is known that these are multifactorial genetic and environmental diseases. While the cause of single gene diseases is better understood, the share of genes in multi-gene diseases is not fully understood. Among the environmental factors that cause neurodegeneration, changes in the immune system are pointed. What is more, in recent years there are more papers suggesting that Alzheimer's disease may have an infectious origin. Bacteria responsible for gum disease, rheumatoid arthritis, and atherosclerosis have been found in the body of deceased people who had Alzheimer's disease.

Recent reports indicate that more than a third of COVID-19 patients have neurological symptoms, including from the central nervous system, even as severe as stroke or impaired consciousness. It has been suggested that an infection has been a risk factor for neurodegenerative diseases. Therefore, increased exposure to infections, especially in people under 60 years of age, may contribute to a greater number of cases of neurodegenerative diseases and their course in the future. Will be after this infection new biomarkers predisposing to the occurrence of old age diseases? Will there be new neuroimaging changes to facilitate early diagnosis of degenerative diseases? Will this knowledge contribute to the development of new, more effective therapies for neurodegenerative diseases?

In this Special Issue, we will try to explain the impact of immune changes associated with infections and their effects on the development of neurodegeneration and the emergence of diseases of old age.


Prof. Jolanta Dorszewska

Guest Editor

Neurodegenerative diseases
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.

Published Paper (2 Papers)
Back to top